Category Archives: News

FIRALIS : The Korean & Japanese market

FIRALIS, a high-tech company specialized in precision medicine and biotechnology. For more than 10 years, this biotech has been developing and commercializing diagnostic products that improve the management of disease in patients and therapeutic decisions, through the discovery and development of biomarkers , with a direct impact for better results incluiding comfort in patients and…
Read more

Firalis contribute to the Pacific CONSORTIUM through its proprietary targeted RNA sequencing tools FiMICS and BIOPRED to redefine heart failure with preserved ejection fraction (HFpEF)

  Major health stakeholders in France launch the PACIFIC Consortium to redefine heart failure with preserved ejection fraction (HFpEF) Paris (France) - January 21, 2019 - Sanofi, Servier, Medicen Paris-Region, BpiFrance, the “Secrétariat Général Pour l’Investissement”, “l’Assistance Publique– Hôpitaux de Paris”, Inserm, Bioserenity, Casis, Fealinx and Firalis announced the launch of the PACIFIC consortium (Physiopathology,…
Read more